Hartman, Tiffiney R.
Demidova, Elena V.
Lesh, Randy W.
Hoang, Lily
Richardson, Marcy
Forman, Andrea
Kessler, Lisa
Speare, Virginia
Golemis, Erica A.
Hall, Michael J.
Daly, Mary B.
Arora, Sanjeevani
Funding for this research was provided by:
Russian Government to support the Program of Competitive Growth of Kazan Federal University
NIH R01 (DK108195)
Colorectal Cancer Alliance
NCI Core Grant P30 (CA006927)
DOD (W81XWH-18-1-0148)
Article History
Received: 21 February 2020
Accepted: 27 July 2020
First Online: 11 August 2020
Competing interests
: A.F. has consulted for Invitae Corporation, and received speaker fees from AstraZeneca, M.J.H. performs collaborative research (with no funding) with the following: Myriad Genetics, Invitae Corporation, Ambry Genetics, Foundation Medicine, Inc. He also performs collaborative research (with no funding) and is part of a Precision Oncology Alliance funded by Caris Life Sciences (cover travel and meals at meetings), L.H., M.R. and V.S. are full-time salaried employees of Ambry Genetics. All other authors report no conflicts or disclosures.